Читать книгу Handbook of Diabetes - Rudy Bilous - Страница 3

1 Chapter 3Table 3.1 Diagnostic criteria for Type 2 diabetes.Table 3.2 Use of HbA1c >6.5% (48 mmol/mol) as a cut‐off for making the diagnosis...Table 3.3 Historically, HbA1c has been reported in percentage values describi...

2 Chapter 4Table 4.1 Criteria that define structured patient education in the NICE guida...Table 4.2 Transformation Funding in the UK in 2017 is targeting 4 key areas t...Table 4.3 Top Tips For Commissioning Diabetes Services.

3 Chapter 6Table 6.1 Highest global rates of incidence per annum of type 1 diabetes in c...Table 6.2 Main non‐ HLA polymorphisms that have been used in predictive model...Table 6.3 Associated foetal, maternal, dietary and environmental factors with...

4 Chapter 7Table 7.1 Definition of metabolic syndrome.

5 Chapter 8Table 8.1 Different genetic aetiologies of main types of MODY.

6 Chapter 9Table 9.1 Available measures of glycaemic control and their main clinical use...Table 9.2 Guide to values of HbA1c (IFCC) and DCCT (NGSP) standardised assay.Table 9.3 Estimated average blood glucose concentration derived from HbA1c re...

7 Chapter 10Table 10.1 Insulin preparations and their costs in the UK based upon the Brit...Table 10.2 Pharmacological properties of the available intermediate and long‐...Table 10.3 Glycaemic targets from NICE (National Institute of Health Care Exc...Table 10.4 Incidence of reported ketoacidosis and severe hypoglycaemia over 3...Table 10.5 Achieved HbA1c on Multiple Daily Injections (MDI) or Continuous Su...

8 Chapter 12Table 12.1 UK and US Diagnostic criteria for DKA and HHS.Table 12.2 Precipitating causes of DKA.Table 12.3 Water and electrolyte deficiencies in DKA and HHS.Table 12.4 Causes of lactic acidosis.

9 Chapter 13Table 13.1 Factors that precipitate or predispose to hypoglycaemia in patient...

10 Chapter 14Table 14.1 Main features of the ACCORD (Action to Control CardiOvascular Risk...

11 Chapter 16Table 16.1 Definition of diabetic nephropathy by albuminuria and test specime...Table 16.2 Stages of chronic kidney disease (CKD) and their mapping to histor...

12 Chapter 17Table 17.1 Treatments for symptomatic diabetic polyneuropathy pain‐dosing and...

13 Chapter 19Table 19.1 Comparison of guidelines for diagnostic thresholds and treatment t...Table 19.2 Stages of hypertension.Table 19.3 Lifestyle changes and the magnitude of reported reduction in blood...Table 19.4 RAS‐blocking agents.Table 19.5 Calcium channel‐blocking agents.Table 19.6 Diuretics.Table 19.7 β‐Blockers.

14 Chapter 21Table 21.1 NICE has recommended this risk stratification system with appropri...Table 21.2 Wagner Ulcer Classification System.Table 21.3 University of Texas Wound Classification System.

15 Chapter 23Table 23.1 Prevalence of gastrointestinal symptoms in diabetes mellitus and c...Table 23.2 Step‐wise approach to the patient with suspected gastroparesis.Table 23.3 A step‐wise approach to the patient with suspected autonomic diarr...

16 Chapter 25Table 25.1 List of cancers and the strength of their reported association wit...Table 25.2 Potential mechanisms linking diabetes and cancer.

17 Chapter 27Table 27.1 Relative risks (95% CI) for type 2 diabetes in people with serious...

18 Chapter 28Table 28.1 Drugs that may exacerbate or provoke hyperglycaemia.

19 Chapter 29Table 29.1 Diagnostic values of plasma glucose for Gestational Diabetes follo...Table 29.2 Recommended blood glucose targets pre‐ and during pregnancy for bo...

20 Chapter 30Table 30.1 Symptoms before diagnosis in 1260 children with type 1 diabetes.Table 30.2 Clinical features of hypoglycaemia in children.

21 Chapter 32Table 32.1 Recommendations for safe driving in people with diabetes taking in...

22 Chapter 33Table 33.1 National Institute of Clinical Excellence (NICE) for diabetes in A...Table 33.2 Pillars of integration.Table 33.3 The 9 Key Care process. Every person with diabetes is supposed to ...

23 Chapter 34Table 34.1 Types of stem cell and their relative advantages and disadvantages...